STRATA CRITICAL MEDICAL, INC. (SRTA) Operating cash flow 2019–2025
STRATA CRITICAL MEDICAL, INC. (SRTA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$48.9MFY2025 · since FY2019: -$10.3M → -$48.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.9M | -1841.8% |
| FY2024 | -$2.5M | +92.2% |
| FY2023 | -$32.3M | +12.9% |
| FY2022 | -$37.1M | -137.8% |
| FY2021 | -$15.6M | -1865.5% |
| FY2020 | -$794,467 | +92.3% |
| FY2019 | -$10.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SRTA financial trends
SRTA RevenueSRTA Net incomeSRTA Net marginSRTA Gross profitSRTA Gross marginSRTA Operating incomeSRTA Operating marginSRTA Free cash flowSRTA Capital expendituresSRTA Return on equitySRTA Stock buybacksSRTA Dividends paidSRTA Total assetsSRTA Total liabilitiesSRTA Shareholders’ equitySRTA overview →